SGCB and Schnyder corneal dystrophy: This result indicates that the increased concentration of oxyhemoglobin in the plasma is inactivating the NO donated by the compound RVT-FxMe before it reaches sGC in CC smooth muscle cells from SCD mice, thus impairing its pharmacological effect.